Association between lower body temperature and increased tau pathology in cognitively normal older adults

Association between lower body temperature and increased tau pathology in cognitively normal older adults

Background: Preclinical studies suggest body temperature (Tb) and consequently brain temperature has the potential to bidirectionally interact with tau pathology in Alzheimer's Disease (AD). Tau phosphorylation is substantially increased by a small (<1 °C) decrease in temperature within the...

Full description

Bibliographic Details
Main Authors:	Esther M. Blessing, Ankit Parekh, Rebecca A. Betensky, James Babb, Natalie Saba, Ludovic Debure, Andrew W. Varga, Indu Ayappa, David M. Rapoport, Tracy A. Butler, Mony J. de Leon, Thomas Wisniewski, Brian J. Lopresti, Ricardo S. Osorio
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	Neurobiology of Disease
Subjects:	Tau Phosphorylation Body temperature Aging Alzheimer's disease Neurofibrillary tangle
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996122001401

Similar Items

de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia
by: Kunie Ando, et al.
Published: (2020-06-01)

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels
by: Melissa E. Murray, et al.
Published: (2022-12-01)

Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
by: Dandan Chu, et al.
Published: (2024-01-01)

Pathology of different tau protein species in neurodegenerative diseases: Alzheimer’s disease, corticobasal degeneration, and progressive supranuclear palsy
by: Mohammad Majidi, et al.
Published: (2021-07-01)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
by: Abdullah Al Mamun, et al.
Published: (2020-01-01)

Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice
by: Céline Héraud, et al.
Published: (2014-02-01)

Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link
by: Andrea González, et al.
Published: (2022-04-01)

Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds
by: Marta Perez-Rando, et al.
Published: (2020-10-01)

Are tau aggregates toxic or protective in tauopathies?
by: Catherine M Cowan, et al.
Published: (2013-08-01)

The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's disease.
by: Paola eFlores-Rodríguez, et al.
Published: (2015-02-01)

Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain
by: Troy T. Rohn, et al.
Published: (2002-11-01)

The Sensitivity of Tau Tracers for the Discrimination of Alzheimer’s Disease Patients and Healthy Controls by PET
by: Zohreh Mohammadi, et al.
Published: (2023-02-01)

Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation
by: Patrick Reilly, et al.
Published: (2017-10-01)

Nuclear Tau and Its Potential Role in Alzheimer’s Disease
by: Mahmoud Bukar Maina, et al.
Published: (2016-01-01)

Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
by: Neha Basheer, et al.
Published: (2024-04-01)

Beyond Amyloid: A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles
by: Martin Nwadiugwu, et al.
Published: (2024-02-01)

Research Progress of Pyroptosis in Alzheimer’s Disease
by: Weiyue Xue, et al.
Published: (2022-06-01)

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
by: Xiao-ying Sun, et al.
Published: (2021-06-01)

Okadaic acid induces damage of human neuroblastoma cell line SH-SY5Y
by: LU Ya-lan, ZHOU Li, HAN Yun-lin, WANG Ke-wei, QIN Chuan
Published: (2022-06-01)

Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches
by: Ayomide Victor Atoki, et al.
Published: (2023-09-01)

Tau: The Center of a Signaling Nexus in Alzheimer’s Disease
by: Shahzad eKhan, et al.
Published: (2016-02-01)

Development, initial validation, and application of a visual read method for [18F]MK‐6240 tau PET
by: Joanna L. Shuping, et al.
Published: (2023-01-01)

Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice
by: Inbal Lahiani-Cohen, et al.
Published: (2020-01-01)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
by: Yuxing Xia, et al.
Published: (2020-06-01)

Differentiating Alzheimer disease-associated aggregates with small molecules
by: Nicolette S. Honson, et al.
Published: (2007-12-01)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
by: Annie G. Bryant, et al.
Published: (2020-09-01)

Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat
by: Ronald L. Klein, et al.
Published: (2005-10-01)

Optimization and Biodistribution of [11C]-TKF, An Analog of Tau Protein Imaging Agent [18F]-THK523
by: Yanyan Kong, et al.
Published: (2016-08-01)

Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in male mouse models
by: M.-A. de Fisenne, et al.
Published: (2022-11-01)

Tau Oligomers and Fibrils Exhibit Differential Patterns of Seeding and Association With RNA Binding Proteins
by: Lulu Jiang, et al.
Published: (2020-09-01)

Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?
by: Cassandra M. Flynn, et al.
Published: (2023-03-01)

Discovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity
by: Taha F. S. Ali, et al.
Published: (2022-03-01)

Effect of exogenous trivalent iron ions on tau phosphorylation and aggregation in SH-SY5Y cells
by: Zhina ZHANG, et al.
Published: (2023-03-01)

Impact of APOE genotype on prion-type propagation of tauopathy
by: Tristan Williams, et al.
Published: (2022-04-01)

Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies
by: Qiuchen Zheng, et al.
Published: (2019-06-01)

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
by: Tomas Smolek, et al.
Published: (2019-12-01)

Neurodegeneration Within the Amygdala Is Differentially Induced by Opioid and HIV-1 Tat Exposure
by: Sara R. Nass, et al.
Published: (2022-05-01)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
by: Tomas Smolek, et al.
Published: (2020-02-01)

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
by: Caitlin V. M. L. Jie, et al.
Published: (2021-01-01)

The Role of Tau Pathology in Alzheimer’s Disease and Down Syndrome
by: Ann-Charlotte Granholm, et al.
Published: (2024-02-01)